alzheimer's foundation for research into alzheimer's disease
alzheimer's foundation for research into alzheimer's disease Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
43-44 crutched friars, crutched friars, london, EC3N 2AE
Website
http://alzheimers.org.ukalzheimer's foundation for research into alzheimer's disease Estimated Valuation
Pomanda estimates the enterprise value of ALZHEIMER'S FOUNDATION FOR RESEARCH INTO ALZHEIMER'S DISEASE at £153.5k based on a Turnover of £309.9k and 0.5x industry multiple (adjusted for size and gross margin).
alzheimer's foundation for research into alzheimer's disease Estimated Valuation
Pomanda estimates the enterprise value of ALZHEIMER'S FOUNDATION FOR RESEARCH INTO ALZHEIMER'S DISEASE at £202k based on an EBITDA of £52.9k and a 3.82x industry multiple (adjusted for size and gross margin).
alzheimer's foundation for research into alzheimer's disease Estimated Valuation
Pomanda estimates the enterprise value of ALZHEIMER'S FOUNDATION FOR RESEARCH INTO ALZHEIMER'S DISEASE at £429.6k based on Net Assets of £182.9k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Alzheimer's Foundation For Research Into Alzheimer's Disease Overview
Alzheimer's Foundation For Research Into Alzheimer's Disease is a live company located in london, EC3N 2AE with a Companies House number of 03655393. It operates in the other human health activities sector, SIC Code 86900. Founded in October 1998, it's largest shareholder is unknown. Alzheimer's Foundation For Research Into Alzheimer's Disease is a mature, micro sized company, Pomanda has estimated its turnover at £309.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Alzheimer's Foundation For Research Into Alzheimer's Disease Health Check
Pomanda's financial health check has awarded Alzheimer'S Foundation For Research Into Alzheimer'S Disease a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 5 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
5 Weak
Size
annual sales of £309.9k, make it smaller than the average company (£721.4k)
£309.9k - Alzheimer's Foundation For Research Into Alzheimer's Disease
£721.4k - Industry AVG
Growth
3 year (CAGR) sales growth of -8%, show it is growing at a slower rate (7.2%)
-8% - Alzheimer's Foundation For Research Into Alzheimer's Disease
7.2% - Industry AVG
Production
with a gross margin of 38.6%, this company has a comparable cost of product (38.6%)
38.6% - Alzheimer's Foundation For Research Into Alzheimer's Disease
38.6% - Industry AVG
Profitability
an operating margin of 17.1% make it more profitable than the average company (5.1%)
17.1% - Alzheimer's Foundation For Research Into Alzheimer's Disease
5.1% - Industry AVG
Employees
with 7 employees, this is below the industry average (18)
- Alzheimer's Foundation For Research Into Alzheimer's Disease
18 - Industry AVG
Pay Structure
on an average salary of £26.4k, the company has an equivalent pay structure (£26.4k)
- Alzheimer's Foundation For Research Into Alzheimer's Disease
£26.4k - Industry AVG
Efficiency
resulting in sales per employee of £44.3k, this is equally as efficient (£45.6k)
- Alzheimer's Foundation For Research Into Alzheimer's Disease
£45.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Alzheimer's Foundation For Research Into Alzheimer's Disease
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Alzheimer's Foundation For Research Into Alzheimer's Disease
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Alzheimer's Foundation For Research Into Alzheimer's Disease
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 57 weeks, this is less cash available to meet short term requirements (126 weeks)
57 weeks - Alzheimer's Foundation For Research Into Alzheimer's Disease
126 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 39%, this is a higher level of debt than the average (22.4%)
39% - Alzheimer's Foundation For Research Into Alzheimer's Disease
22.4% - Industry AVG
ALZHEIMER'S FOUNDATION FOR RESEARCH INTO ALZHEIMER'S DISEASE financials
Alzheimer'S Foundation For Research Into Alzheimer'S Disease's latest turnover from March 2024 is £309.9 thousand and the company has net assets of £182.9 thousand. According to their latest financial statements, we estimate that Alzheimer'S Foundation For Research Into Alzheimer'S Disease has 7 employees and maintains cash reserves of £128.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 309,884 | 108,363 | 32,515 | 391,685 | 65,737 | 693,216 | 313,578 | 324,335 | 144,673 | 298,595 | 78,212 | 150,520 | 245,518 | 212,630 | 344,363 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | 22 | 13 | |||||||||||||
| Pre-Tax Profit | 42,442 | -7,873 | -93,573 | 346,915 | -38,908 | -231,469 | 261,210 | 20,019 | -109,595 | -175,554 | 73,725 | 146,350 | -178,909 | -91,176 | 40,515 |
| Tax | |||||||||||||||
| Profit After Tax | 42,442 | -7,873 | -93,573 | 346,915 | -38,908 | -231,469 | 261,210 | 20,019 | -109,595 | -175,554 | 73,725 | 146,350 | -178,909 | -91,176 | 40,515 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 42,442 | -7,873 | -93,573 | 346,915 | -38,908 | -231,469 | 261,210 | 20,019 | -109,595 | -175,554 | 73,725 | 146,350 | -178,909 | -91,176 | 40,515 |
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | |||||||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 258,885 | 15,321 | 60,370 | ||||||||||||
| Group Debtors | 59 | 100,000 | 7,843 | 300,020 | 20,173 | 22,557 | 107,299 | 118,239 | 202,232 | 68,978 | 235,380 | 139,676 | |||
| Misc Debtors | 171,095 | 135,176 | 115,176 | ||||||||||||
| Cash | 128,838 | 11,259 | 39,073 | 25,176 | 13,862 | 15,444 | 7,023 | 25,660 | 3,257 | 28,110 | 192,844 | 34,906 | 21,790 | 34,017 | 220,897 |
| misc current assets | |||||||||||||||
| total current assets | 299,933 | 146,435 | 154,308 | 384,061 | 37,026 | 75,814 | 307,043 | 45,833 | 25,814 | 135,409 | 311,083 | 237,138 | 90,768 | 269,397 | 360,573 |
| total assets | 299,933 | 146,435 | 154,308 | 384,061 | 37,026 | 75,814 | 307,043 | 45,833 | 25,814 | 135,409 | 311,083 | 237,138 | 90,768 | 269,397 | 360,573 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 117,056 | 6,000 | 6,000 | 4,680 | 4,560 | 4,440 | 4,200 | 4,200 | 4,200 | 4,200 | 4,320 | 4,100 | 4,080 | 3,800 | 3,800 |
| total current liabilities | 117,056 | 6,000 | 6,000 | 4,680 | 4,560 | 4,440 | 4,200 | 4,200 | 4,200 | 4,200 | 4,320 | 4,100 | 4,080 | 3,800 | 3,800 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 117,056 | 6,000 | 6,000 | 4,680 | 4,560 | 4,440 | 4,200 | 4,200 | 4,200 | 4,200 | 4,320 | 4,100 | 4,080 | 3,800 | 3,800 |
| net assets | 182,877 | 140,435 | 148,308 | 379,381 | 32,466 | 71,374 | 302,843 | 41,633 | 21,614 | 131,209 | 306,763 | 233,038 | 86,688 | 265,597 | 356,773 |
| total shareholders funds | 182,877 | 140,435 | 148,308 | 379,381 | 32,466 | 71,374 | 302,843 | 41,633 | 21,614 | 131,209 | 306,763 | 233,038 | 86,688 | 265,597 | 356,773 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 35,919 | 19,941 | -243,650 | 335,721 | -37,206 | -239,650 | 279,847 | -2,384 | -84,742 | -10,940 | -83,993 | 133,254 | -166,402 | 95,704 | 139,676 |
| Creditors | |||||||||||||||
| Accruals and Deferred Income | 111,056 | 1,320 | 120 | 120 | 240 | -120 | 220 | 20 | 280 | 3,800 | |||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 22 | 13 | |||||||||||||
| cash flow from financing | -137,500 | 22 | 13 | 316,258 | |||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 117,579 | -27,814 | 13,897 | 11,314 | -1,582 | 8,421 | -18,637 | 22,403 | -24,853 | -164,734 | 157,938 | 13,116 | -12,227 | -186,880 | 220,897 |
| overdraft | |||||||||||||||
| change in cash | 117,579 | -27,814 | 13,897 | 11,314 | -1,582 | 8,421 | -18,637 | 22,403 | -24,853 | -164,734 | 157,938 | 13,116 | -12,227 | -186,880 | 220,897 |
alzheimer's foundation for research into alzheimer's disease Credit Report and Business Information
Alzheimer's Foundation For Research Into Alzheimer's Disease Competitor Analysis
Perform a competitor analysis for alzheimer's foundation for research into alzheimer's disease by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in EC3N area or any other competitors across 12 key performance metrics.
alzheimer's foundation for research into alzheimer's disease Ownership
ALZHEIMER'S FOUNDATION FOR RESEARCH INTO ALZHEIMER'S DISEASE group structure
Alzheimer'S Foundation For Research Into Alzheimer'S Disease has no subsidiary companies.
Ultimate parent company
ALZHEIMER'S FOUNDATION FOR RESEARCH INTO ALZHEIMER'S DISEASE
03655393
alzheimer's foundation for research into alzheimer's disease directors
Alzheimer'S Foundation For Research Into Alzheimer'S Disease currently has 4 directors. The longest serving directors include Mr Alex Hyde-Smith (Oct 2019) and Mrs Kate Lee (Sep 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Alex Hyde-Smith | England | 53 years | Oct 2019 | - | Director |
| Mrs Kate Lee | England | 52 years | Sep 2021 | - | Director |
| Mr Andrew Lynch | 68 years | Mar 2024 | - | Director | |
| Mr Simon Morris | England | 64 years | Jun 2024 | - | Director |
P&L
March 2024turnover
309.9k
+186%
operating profit
52.9k
0%
gross margin
38.7%
+2.1%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
182.9k
+0.3%
total assets
299.9k
+1.05%
cash
128.8k
+10.44%
net assets
Total assets minus all liabilities
alzheimer's foundation for research into alzheimer's disease company details
company number
03655393
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
October 1998
age
27
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2024
previous names
the alzheimer's disease research fund (April 1999)
accountant
-
auditor
BDO LLP
address
43-44 crutched friars, crutched friars, london, EC3N 2AE
Bank
THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
alzheimer's foundation for research into alzheimer's disease Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to alzheimer's foundation for research into alzheimer's disease.
alzheimer's foundation for research into alzheimer's disease Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ALZHEIMER'S FOUNDATION FOR RESEARCH INTO ALZHEIMER'S DISEASE. This can take several minutes, an email will notify you when this has completed.
alzheimer's foundation for research into alzheimer's disease Companies House Filings - See Documents
| date | description | view/download |
|---|
